First-in-human study of an optimized, potential kit-type, SSTR antagonist 68 Ga-DATA 5m -LM4 in patients with metastatic neuroendocrine tumors
Theranostics · 2025
DOI: 10.7150/thno.94521 ↗Kurz gefasst
Fachartikel in der Zeitschrift Theranostics, 2025. Verfasst von Jingjing Zhang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Diagnostic Radiology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore. Hauptthemen laut MEDLINE: Neuroendocrine Tumors, Receptors, Somatostatin, Gallium Radioisotopes, Radiopharmaceuticals. Die Arbeit wurde bisher 6-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Diagnostic Radiology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.
- Theranostics Center of Excellence, Yong Loo Lin School of Medicine, National University of Singapore, 11 Biopolis Way, Helios, Singapore 138667, Singapore.
- Clinical Imaging Research Centre, Centre for Translational Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.
- Nanomedicine Translational Research Program, NUS Center for Nanomedicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.
- Curanosticum Wiesbaden-Frankfurt, Center for Advanced Radiomolecular Precision Oncology, Wiesbaden, Germany.
- Academy for Precision Oncology, International Centers for Precision Oncology (ICPO), Wiesbaden, Germany.
Zitieren
APA
Zhang, J., Greifenstein, L., Jakobsson, V., Zan, E., Klega, A., Rösch, F., Landvogt, C., Mueller, C., & Baum, R. P. (2025). First-in-human study of an optimized, potential kit-type, SSTR antagonist 68 Ga-DATA 5m -LM4 in patients with metastatic neuroendocrine tumors. Theranostics. https://doi.org/10.7150/thno.94521
Vancouver
Zhang J, Greifenstein L, Jakobsson V, Zan E, Klega A, Rösch F, et al. First-in-human study of an optimized, potential kit-type, SSTR antagonist 68 Ga-DATA 5m -LM4 in patients with metastatic neuroendocrine tumors. Theranostics. 2025. doi:10.7150/thno.94521
BibTeX
@article{Zhang2025,
author = {Zhang, Jingjing and Greifenstein, Lukas and Jakobsson, Vivianne and Zan, Elcin and Klega, Andre and Rösch, Frank and Landvogt, Christian and Mueller, Corinna and Baum, Richard P},
title = {First-in-human study of an optimized, potential kit-type, SSTR antagonist 68 Ga-DATA 5m -LM4 in patients with metastatic neuroendocrine tumors},
journal = {Theranostics},
year = {2025},
doi = {10.7150/thno.94521}
}
EUVIMED